CLINICAL_TRIALS
trial_result
· 2011-07-06
Clinical Trial Update: Efficacy Study of Metadoxine SR Formulation in Attention Deficit Hyperactivity Disorder (ADHD) Subjects [Phase 1]
Summary
A Phase 1 efficacy study of Metadoxine SR in Attention Deficit Hyperactivity Disorder has completed with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcobra Ltd. | Conditions: Attention Deficit Hyperactivity Disorder | Phase 1 | Status: COMPLETED | Results posted: 2011-07-06